Purinergic signalling and disorders of the central nervous system (original) (raw)

• Burnstock, G. Purinergic nerves. Pharmacol. Rev. 24, 509–581 (1972).
  CAS PubMed Google Scholar
• Burnstock, G., Campbell, G., Satchell, D. & Smythe, A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol. 40, 668–688 (1970).
  CAS PubMed PubMed Central Google Scholar
• Burnstock, G. Do some nerve cells release more than one transmitter? Neuroscience 1, 239–248 (1976).
  CAS PubMed Google Scholar
• Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659–797 (2007). A recent, comprehensive review of purinergic signalling in the nervous system.
  CAS PubMed Google Scholar
• Burnstock, G. A basis for distinguishing two types of purinergic receptor, in Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (eds Straub, R. W. & Bolis, L.) 107–118 (Raven Press, New York, 1978).
  Google Scholar
• Burnstock, G. & Kennedy, C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol. 16, 433–440 (1985).
  CAS PubMed Google Scholar
• Ralevic, V. & Burnstock, G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413–492 (1998).
  CAS PubMed Google Scholar
• Abbracchio, M. P. et al. International Union of Pharmacology. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58, 281–341 (2006).
  CAS PubMed Google Scholar
• Burnstock, G. Purine and pyrimidine receptors. Cellular and Molecular Life Sciences 64, 1471–1483 (2007). A recent update of subtypes of receptors for purines and pyrimidines.
  CAS PubMed Google Scholar
• Köles, L., Fürst, S. & Illes, P. Purine ionotropic (P2X) receptors. Curr. Pharm. Des. 13, 2368–2384 (2007).
  PubMed Google Scholar
• North, R. A. & Verkhratsky, A. Purinergic transmission in the central nervous system. Pflugers Arch. 452, 479–485 (2006).
  CAS PubMed Google Scholar
• Bonan, C. D., Schetinger, M. R., Battastini, A. M. & Sarkis, J. J. Ectonucleotidases and synaptic plasticity: implications in physiological and pathological conditions. Drug Dev. Res. 52, 57–65 (2001).
  CAS Google Scholar
• Burnstock, G. & Knight, G. E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31–304 (2004).
  CAS PubMed Google Scholar
• Fields, D. & Burnstock, G. Purinergic signalling in neuron–glial interactions. Nature Rev. Neurosci. 7, 423–436 (2006). A review of the growing recognition of the involvement of purinergic signalling in neuron–glial interactions in the CNS.
  CAS Google Scholar
• Inoue, K., Koizumi, S. & Tsuda, M. The role of nucleotides in the neuron-glia communication responsible for the brain functions. J. Neurochem. 102, 1447–1458 (2007).
  CAS PubMed Google Scholar
• Abbracchio, M. P. & Burnstock, G. Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 78, 113–145 (1998).
  CAS PubMed Google Scholar
• Mishra, S. K. et al. Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 133, 675–684 (2006).
  CAS PubMed Google Scholar
• Neary, J. T. et al. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19, 13–18 (1996).
  CAS PubMed Google Scholar
• Pankratov, Y. V., Lalo, U. V. & Krishtal, O. A. Role for P2X receptors in long-term potentiation. J. Neurosci. 22, 8363–8369 (2002).
  CAS PubMed PubMed Central Google Scholar
• Pedrazza, E. L. et al. Habituation to an open field alters ecto-nucleotidase activities in rat hippocampal synaptosomes. Neurosci. Lett. 413, 21–24 (2007).
  CAS PubMed Google Scholar
• Basheer, R., Strecker, R. E., Thakkar, M. M. & McCarley, R. W. Adenosine and sleep-wake regulation. Prog. Neurobiol. 73, 379–396 (2004).
  CAS PubMed Google Scholar
• Barraco, R., Martens, K. A., Parizon, M. & Normile, H. J. Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression. Brain Res. Bull. 31, 397–404 (1993).
  CAS PubMed Google Scholar
• Florenzano, F. et al. P2X2R purinergic receptor subunit mRNA and protein are expressed by all hypothalamic hypocretin/orexin neurons. J. Comp. Neurol. 498, 58–67 (2006).
  CAS PubMed Google Scholar
• Brockhaus, J., Dressel, D., Herold, S. & Deitmer, J. W. Purinergic modulation of synaptic input to Purkinje neurons in rat cerebellar brain slices. Eur. J. Neurosci. 19, 2221–2230 (2004).
  PubMed Google Scholar
• Kittner, H., Krügel, U., Hoffmann, E. & Illes, P. Modulation of feeding behaviour by blocking purinergic receptors in the rat nucleus accumbens: a combined microdialysis, electroencephalographic and behavioural study. Eur. J. Neurosci. 19, 396–404 (2004).
  CAS PubMed Google Scholar
• Kittner, H. et al. Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides. Eur. J. Neurosci. 24, 2049–2056 (2006).
  PubMed Google Scholar
• Franke, H., Krügel, U. & Illes, P. P2 receptors and neuronal injury. Pflugers Arch. 452, 622–644 (2006). A valuable review of the roles of P2 receptors in neuronal injury and regeneration.
  CAS PubMed Google Scholar
• Neary, J. T., Kang, Y., Tran, M. & Feld, J. Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J. Neurotrauma 22, 491–500 (2005).
  PubMed Google Scholar
• Neary, J. T. et al. P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell–cell interactions. Novartis Found. Symp. 276, 131–143 (2006). A good review of the trophic roles of purines and pyrimidines in the CNS.
  CAS PubMed Google Scholar
• Tran, M. D. & Neary, J. T. Purinergic signaling induces thrombospondin-1 expression in astrocytes. Proc. Natl Acad. Sci. USA. 103, 9321–9326 (2006).
  CAS PubMed PubMed Central Google Scholar
• Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neurosci. 8, 752–758 (2005). An important experimental study of the neuroprotective roles of ATP.
  CAS PubMed Google Scholar
• Färber, K. & Kettenmann, H. Purinergic signaling and microglia. Pflugers Arch. 452, 615–621 (2006). An important summary of the roles of purinoceptors expressed in microglia.
  PubMed Google Scholar
• Neary, J. T., Kang, Y., Willoughby, K. A. & Ellis, E. F. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J. Neurosci. 23, 2348–2356 (2003).
  CAS PubMed PubMed Central Google Scholar
• Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nature Neurosci. 9, 1512–1519 (2006).
  CAS PubMed Google Scholar
• Ohsawa, K. et al. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 55, 604–616 (2007).
  PubMed Google Scholar
• Xiang, Z. et al. Microglial morphology and its transformation after challenge by extracellular ATP in vitro. J. Neurosci. Res. 83, 91–101 (2006).
  CAS PubMed Google Scholar
• Koizumi, S. et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446, 1091–1095 (2007).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Z. et al. Lesional accumulation of P2X4 receptor+ monocytes following experimental traumatic brain injury. Exp. Neurol. 197, 252–257 (2006).
  CAS PubMed Google Scholar
• Bianco, F. et al. A role for P2X7 in microglial proliferation. J. Neurochem. 99, 745–758 (2006).
  CAS PubMed Google Scholar
• Franke, H. & Illes, P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol. Ther. 109, 297–324 (2006).
  CAS PubMed Google Scholar
• Washburn, K. B. & Neary, J. T. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation. Neuroscience 142, 411–423 (2006).
  CAS PubMed Google Scholar
• Brambilla, R. et al. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol. 126, 563–567 (1999).
  CAS PubMed PubMed Central Google Scholar
• Florenzano, F. et al. Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei. Neuroscience 115, 425–434 (2002).
  CAS PubMed Google Scholar
• Arthur, D. B., Georgi, S., Akassoglou, K. & Insel, P. A. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J. Neurosci. 26, 3798–3804 (2006).
  CAS PubMed PubMed Central Google Scholar
• Chorna, N. E. et al. P2Y2 receptors activate neuroprotective mechanisms in astrocytic cells. J. Neurochem. 91, 119–132 (2004).
  CAS PubMed Google Scholar
• Inoue, K. ATP receptors for the protection of hippocampal functions. Jpn. J. Pharmacol. 78, 405–410 (1998).
  CAS PubMed Google Scholar
• Franke, H. et al. Changes in purinergic signaling after cerebral injury — involvement of glutamatergic mechanisms? Int. J. Dev. Neurosci. 24, 123–132 (2006).
  CAS PubMed Google Scholar
• Matute, C. et al. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 27, 9525–9533 (2007). An experimental study of the role of P2X 7 receptors in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nature Med. 10, 821–827 (2004).
  CAS PubMed Google Scholar
• Sperlágh, B. et al. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience 149, 99–111 (2007). A paper describing the purinergic modulation of glutamate release in ischaemic hippocampus.
  PubMed Google Scholar
• Aihara, H. et al. Adenosine triphosphate accelerates recovery from hypoxic/hypoglycemic perturbation of guinea pig hippocampal neurotransmission via a P2 receptor. Brain Res. 952, 31–37 (2002).
  CAS PubMed Google Scholar
• Lämmer, A. et al. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur. J. Neurosci. 23, 2824–2828 (2006).
  PubMed Google Scholar
• Braun, N. et al. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J. Neurosci. 18, 4891–4900 (1998).
  CAS PubMed PubMed Central Google Scholar
• Cavaliere, F. et al. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120, 85–98 (2003).
  CAS PubMed Google Scholar
• Frenguelli, B. G., Wigmore, G., Llaudet, E. & Dale, N. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem. 101, 1400–1413 (2007).
  CAS PubMed PubMed Central Google Scholar
• Franke, H. et al. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 63, 686–699 (2004).
  CAS PubMed Google Scholar
• Melani, A. et al. P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 26, 974–982 (2006).
  CAS PubMed Google Scholar
• Wirkner, K. et al. Supersensitivity of P2X7 receptors in cerebrocortical cell cultures after in vitro ischemia. J. Neurochem. 95, 1421–1437 (2005).
  CAS PubMed Google Scholar
• Le Feuvre, R. A., Brough, D., Touzani, O. & Rothwell, N. J. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 23, 381–384 (2003).
  CAS PubMed Google Scholar
• Cavaliere, F., Dinkel, K. & Reymann, K. Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage. Neuroscience 136, 615–623 (2005).
  CAS PubMed Google Scholar
• Zhang, Y., Deng, P., Li, Y. & Xu, Z. C. Enhancement of excitatory synaptic transmission in spiny neurons after transient forebrain ischemia. J. Neurophysiol. 95, 1537–1544 (2006).
  PubMed Google Scholar
• Schock, S. C. et al. Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance. Brain Res. 1168, 129–138 (2007).
  CAS PubMed Google Scholar
• Pedata, F. et al. The role of ATP and adenosine in the brain under normoxic and ischemic conditions. Purinergic Signal. 3, 299–310 (2007).
  CAS PubMed PubMed Central Google Scholar
• Chen, H. H. et al. Extracellular ATP-dependent upregulation of the transcription cofactor LMO4 promotes neuron survival from hypoxia. Exp. Cell Res. 313, 3106–3116 (2007).
  CAS PubMed Google Scholar
• Briede, J. & Duburs, G. Protective effect of cerebrocrast on rat brain ischaemia induced by occlusion of both common carotid arteries. Cell Biochem. Funct. 25, 203–210 (2007).
  CAS PubMed Google Scholar
• Volonté, C. et al. Extracellular ATP and neurodegeneration. Curr. Drug Targets. CNS Neurol. Disord. 2, 403–412 (2003).
  PubMed Google Scholar
• Watanabe, S., Yoshimi, Y. & Ikekita, M. Neuroprotective effect of adenine on purkinje cell survival in rat cerebellar primary cultures. J. Neurosci. Res. 74, 754–759 (2003).
  CAS PubMed Google Scholar
• Ogata, T. et al. Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors. Brain Res. 981, 174–183 (2003).
  CAS PubMed Google Scholar
• Purcell, W. M. & Atterwill, C. K. Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem. Res. 20, 521–532 (1995).
  CAS PubMed Google Scholar
• Calon, F. et al. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain 127, 1075–1084 (2004).
  PubMed Google Scholar
• Ismayilova, N., Crossman, A., Verkhratsky, A. & Brotchie, J. Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats. Eur. J. Pharmacol. 497, 187–195 (2004).
  CAS PubMed Google Scholar
• Schwarzschild, M. A. Targeting adenosine A2A receptors in Parkinson's disease and other CNS disorders. Prog. Neurobiol. 83, 261–347 (2007). Review of therapeutic treatment of Parkinson's disease with A 2A receptor antagonists.
  PubMed PubMed Central Google Scholar
• Jun, D. & Kim, K. ATP-mediated necrotic volume increase (NVI) in substantia nigra pars compacta dopaminergic neuron. Society for Neuroscience, Washington, DC. Abstr. 222, 18 (2004).
  Google Scholar
• Heine, C. et al. P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience 149, 165–181 (2007).
  CAS PubMed Google Scholar
• Morales, I. et al. Substantia nigra osmoregulation: taurine and ATP involvement. Am. J. Physiol. Cell Physiol. 292, C1934–C1941 (2007).
  CAS PubMed Google Scholar
• Jacobson, K. A. et al. Agonists and antagonists for P2 receptors, in Novartis Foundation Symposium 276 Purinergic Signalling in Neuron–Glial Interactions 58–68 (John Wiley & Sons Ltd., Chichester, 2006). Detailed account of the medicinal chemistry of P2 receptor agonists and antagonists.
  Google Scholar
• Xu, J. et al. Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot. Essent. Fatty Acids 69, 437–448 (2003).
  CAS PubMed Google Scholar
• Parvathenani, L. K. et al. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278, 13309–13317 (2003).
  CAS PubMed Google Scholar
• McLarnon, J. G., Ryu, J. K., Walker, D. G. & Choi, H. B. Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65, 1090–1097 (2006). This study shows an upregulation of P2X 7 receptors in Alzheimer's disease.
  CAS PubMed Google Scholar
• Rampe, D., Wang, L. & Ringheim, G. E. P2X7 receptor modulation of β-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J. Neuroimmunol. 147, 56–61 (2004).
  CAS PubMed Google Scholar
• Tumini, E. et al. The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. Hum. Psychopharmacol. 22, 75–80 (2007).
  CAS PubMed Google Scholar
• Moore, D., Iritani, S., Chambers, J. & Emson, P. Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease. Neuroreport 11, 3799–3803 (2000).
  CAS PubMed Google Scholar
• Camden, J. M. et al. P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing. J. Biol. Chem. 280, 18696–18702 (2005).
  CAS PubMed Google Scholar
• McLarnon, J. G. et al. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. J. Neurosci. Res. 81, 426–435 (2005).
  CAS PubMed Google Scholar
• Kalaria, R. N., Sromek, S., Wilcox, B. J. & Unnerstall, J. R. Hippocampal adenosine A1 receptors are decreased in Alzheimer's disease. Neurosci. Lett. 118, 257–260 (1990).
  CAS PubMed Google Scholar
• Angulo, E. et al. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 13, 440–451 (2003).
  CAS PubMed Google Scholar
• Martinez-Mir, M. I., Probst, A. & Palacios, J. M. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 42, 697–706 (1991).
  CAS PubMed Google Scholar
• Popoli, P. et al. Adenosine A2A receptor blockade prevents EEG and motor abnormalities in a rat model of Huntington's disease. Drug Dev. Res. 50, 69 (2000)
  Google Scholar
• Bauer, A. et al. Striatal loss of A1 adenosine receptors in Huntington's disease — a PET study. J. Neural Transm. 114, XXI (2007).
  Google Scholar
• Tarditi, A. et al. Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease. Neurobiol. Dis. 23, 44–53 (2006).
  CAS PubMed Google Scholar
• Popoli, P. et al. Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease. Prog. Neurobiol. 81, 331–348 (2007). A review of the therapeutic potential of A 2A receptors in Huntington's disease.
  CAS PubMed Google Scholar
• Diez-Zaera, M. et al. Purinergic system in Huntington's disease: development of new therapeutic strategies. J. Neurochem. 101, S66 (2007).
  Google Scholar
• Andries, M., Van Damme, P., Robberecht, W. & Van Den Bosch, L. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 25, 8–16 (2007).
  CAS PubMed Google Scholar
• Kassa, R. M., Bentivoglio, M. & Mariotti, R. Changes in the expression of P2X1 and P2X2 purinergic receptors in facial motoneurons after nerve lesions in rodents and correlation with motoneuron degeneration. Neurobiol. Dis. 25, 121–133 (2007).
  CAS PubMed Google Scholar
• Trudeau, F., Gagnon, S. & Massicotte, G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur. J. Pharmacol. 490, 177–186 (2004).
  CAS PubMed Google Scholar
• Cox, D. J. et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28, 71–77 (2005).
  PubMed Google Scholar
• Duarte, J. M., Oses, J. P., Rodrigues, R. J. & Cunha, R. A. Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats. Neuroscience 149, 382–391 (2007).
  CAS PubMed Google Scholar
• Lucas, S. M., Rothwell, N. J. & Gibson, R. M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, S232–S240 (2006).
  CAS PubMed PubMed Central Google Scholar
• Bours, M. J. et al. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112, 358–404 (2006).
  CAS PubMed Google Scholar
• Sperlágh, B. & Illes, P. Purinergic modulation of microglial cell activation. Purinergic Signal. 3, 117–127 (2007).
  PubMed Google Scholar
• Marchand, F., Perretti, M. & McMahon, S. B. Role of the immune system in chronic pain. Nature Rev. Neurosci. 6, 521–532 (2005).
  CAS Google Scholar
• Moalem, G. & Tracey, D. J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 51, 240–264 (2006).
  CAS PubMed Google Scholar
• Ferrari, D., Stroh, C. & Schulze-Osthoff, K. P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J. Biol. Chem. 274, 13205–13210 (1999).
  CAS PubMed Google Scholar
• Potucek, Y. D., Crain, J. M. & Watters, J. J. Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem. Int. 49, 204–214 (2006).
  CAS PubMed Google Scholar
• Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417–426 (2002).
  CAS PubMed Google Scholar
• Di Virgilio, F. Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol. Sci. 28, 465–472 (2007). A valuable account of the role of P2X 7 receptors in immune responses in brain.
  CAS PubMed Google Scholar
• Suzuki, T. et al. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J. Neurosci. 24, 1–7 (2004).
  CAS PubMed PubMed Central Google Scholar
• Lemaire, I. et al. Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. J. Immunol. 177, 7257–7265 (2006).
  CAS PubMed Google Scholar
• Takenouchi, T., Sato, M. & Kitani, H. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J. Neurochem. 102, 1518–1532 (2007).
  CAS PubMed Google Scholar
• Takenouchi, T. et al. Prion infection correlates with hypersensitivity of P2X7 nucleotide receptor in a mouse microglial cell line. FEBS Lett. 581, 3019–3026 (2007).
  CAS PubMed Google Scholar
• Guo, L. H., Trautmann, K. & Schluesener, H. J. Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain. J. Neuroimmunol. 163, 120–127 (2005).
  CAS PubMed Google Scholar
• Raouf, R. et al. Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. Neuropharmacology 53, 496–504 (2007).
  CAS PubMed Google Scholar
• Abbracchio, M. P. & Verderio, C. Pathophysiological roles of P2 receptors in glial cells, in Novartis Foundation Symposium 276 Purinergic Signalling in Neuron–Glial Interactions 91–103 (John Wiley & Sons Ltd., Chichester, 2006).
  Google Scholar
• Panenka, W. et al. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21, 7135–7142 (2001).
  CAS PubMed PubMed Central Google Scholar
• Agresti, C. et al. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors. Brain Res. Brain Res. Rev. 48, 157–165 (2005).
  CAS PubMed Google Scholar
• Narcisse, L. et al. The cytokine IL-1β transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 49, 245–258 (2005).
  PubMed PubMed Central Google Scholar
• Spanevello, R. M. et al. Apyrase and 5′-nucleotidase activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon-β. Neurochem. Res. 31, 455–462 (2006).
  CAS PubMed Google Scholar
• Guo, L. H. & Schluesener, H. J. Lesional accumulation of P2X4 receptor+ macrophages in rat CNS during experimental autoimmune encephalomyelitis. Neuroscience 134, 199–205 (2005).
  CAS PubMed Google Scholar
• Chen, L. & Brosnan, C. F. Exacerbation of experimental autoimmune encephalomyelitis in P2X7R−/− mice: evidence for loss of apoptotic activity in lymphocytes. J. Immunol. 176, 3115–3126 (2006).
  CAS PubMed Google Scholar
• Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225–1232 (2007).
  CAS PubMed Google Scholar
• Knutsen, L. J. S. & Murray, T. F. Adenosine and ATP in epilepsy, in Purinergic Approaches in Experimental Therapeutics (eds Jacobson, K. A. & Jarvis, M. F.) 423–447 (Wiley-Liss, New York, 1997).
  Google Scholar
• Ross, F. M., Brodie, M. J. & Stone, T. W. Modulation by adenine nucleotides of epileptiform activity in the CA3 region of rat hippocampal slices. Br. J. Pharmacol. 123, 71–80 (1998).
  CAS PubMed PubMed Central Google Scholar
• Vianna, E. P. et al. Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43, 227–229 (2002).
  CAS PubMed Google Scholar
• Rappold, P. M., Lynd-Balta, E. & Joseph, S. A. P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res. 1089, 171–178 (2006).
  CAS PubMed Google Scholar
• Wieraszko, A. & Seyfried, T. N. Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci. Lett. 106, 287–293 (1989). An important early experimental study of ATP release in the hippocampus during seizures.
  CAS PubMed Google Scholar
• Slézia, A. et al. Uridine release during aminopyridine-induced epilepsy. Neurobiol. Dis 16, 490–499 (2004).
  PubMed Google Scholar
• Nicolaidis, R., Bruno, A. N., Sarkis, J. J. & Souza, D. O. Increase of adenine nucleotide hydrolysis in rat hippocampal slices after seizures induced by quinolinic acid. Neurochem. Res. 30, 385–390 (2005).
  CAS PubMed Google Scholar
• Oses, J. P. Modification by kainate-induced convulsions of the density of presynaptic P2X receptors in the rat hippocampus. Purinergic Signal. 2, 252–253 (2006).
  Google Scholar
• Tian, G. F. et al. An astrocytic basis of epilepsy. Nature Med. 11, 973–981 (2005).
  CAS PubMed Google Scholar
• Dragunow, M. Purinergic mechanisms in epilepsy. Prog. Neurobiol. 31, 85–108 (1988).
  CAS PubMed Google Scholar
• Zeraati, M. et al. Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats. Seizure 15, 41–48 (2006). A study of the roles of adenosine receptors in seizures.
  PubMed Google Scholar
• Dulla, C. G. et al. Adenosine and ATP link PCO2 to cortical excitability via pH. Neuron 48, 1011–1023 (2005).
  CAS PubMed PubMed Central Google Scholar
• Ekonomou, A., Angelatou, F., Vergnes, M. & Kostopoulos, G. Lower density of A1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy. Neuroreport 9, 2135–2140 (1998).
  CAS PubMed Google Scholar
• Machado-Vieira, R., Lara, D. R., Souza, D. O. & Kapczinski, F. Purinergic dysfunction in mania: an integrative model. Med. Hypotheses 58, 297–304 (2002).
  CAS PubMed Google Scholar
• Lam, P., Hong, C. J. & Tsai, S. J. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci. Lett. 378, 98–101 (2005).
  CAS PubMed Google Scholar
• Williams, M. Purinergic receptors and central nervous system function, in Psychopharmacology: The Third Generation of Progress (ed. Meltzer, H. Y.) 289–301 (Raven Press, New York, 1987).
  Google Scholar
• Ward, R. P. & Dorsa, D. M. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-HT4 or 5-HT6 receptors following antipsychotic administration. Neuroscience 89, 927–938 (1999).
  CAS PubMed Google Scholar
• Chen, J. F. et al. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A2A adenosine receptors. Neuroscience 97, 195–204 (2000).
  CAS PubMed Google Scholar
• Judelson, D. A. et al. Effect of chronic caffeine intake on choice reaction time, mood, and visual vigilance. Physiol. Behav. 85, 629–634 (2005).
  CAS PubMed Google Scholar
• Wagner, J. A. & Katz, R. J. Purinergic control of anxiety: direct behavioral evidence in the rat. Neurosci. Lett. 43, 333–337 (1983).
  CAS PubMed Google Scholar
• Johansson, B. et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl Acad. Sci. USA. 98, 9407–9412 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kittner, H. et al. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology 28, 435–444 (2003).
  CAS PubMed Google Scholar
• Vinadé, E. R. et al. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res. 977, 97–102 (2003).
  PubMed Google Scholar
• Kaster, M. P. et al. Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors. Neurosci. Lett. 355, 21–24 (2004). A study describing the involvement of A 1 and A 2A receptors in depression.
  CAS PubMed Google Scholar
• Alesci, S. et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 90, 2522–2530 (2005).
  CAS PubMed Google Scholar
• Lucae, S. et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol. Genet. 15, 2438–2445 (2006). A description of the involvement of P2X 7 receptors in depression.
  CAS PubMed Google Scholar
• Barden, N. et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 374–382 (2006).
  Google Scholar
• Busnello, J. V. et al. Acute and chronic electroconvulsive shock in rats: effects on peripheral markers of neuronal injury and glial activity. Life Sci. 78, 3013–3017 (2006).
  CAS PubMed Google Scholar
• Ushijima, I. et al. Effects of dilazep (Comelian) on the central purinergic system: inhibitory effects on clonidine-induced aggressive behavior. Eur. J. Pharmacol. 161, 245–248 (1989).
  CAS PubMed Google Scholar
• Zou, C. J., Onaka, T. O. & Yagi, K. Effects of suramin on neuroendocrine and behavioural responses to conditioned fear stimuli. Neuroreport 9, 997–999 (1998).
  CAS PubMed Google Scholar
• Corodimas, K. P. & Tomita, H. Adenosine A1 receptor activation selectively impairs the acquisition of contextual fear conditioning in rats. Behav. Neurosci. 115, 1283–1290 (2001).
  CAS PubMed Google Scholar
• Krügel, U. et al. P2 receptors are involved in the mediation of motivation-related behavior. Purinergic Signal. 1, 21–29 (2004).
  PubMed PubMed Central Google Scholar
• Short, J. L., Ledent, C., Drago, J. & Lawrence, A. J. Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors. Neuropsychopharmacology 31, 525–534 (2006).
  CAS PubMed Google Scholar
• Van Calker, D. & Biber, K. The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders. Neurochem. Res. 30, 1205–1217 (2005).
  PubMed Google Scholar
• Inoue, K., Koizumi, S. & Ueno, S. Implication of ATP receptors in brain functions. Prog. Neurobiol. 50, 483–492 (1996).
  CAS PubMed Google Scholar
• Lara, D. R., Dall'Igna, O. P., Ghisolfi, E. S. & Brunstein, M. G. Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 617–629 (2006). This paper suggests that adenosine A 1 receptors are involved in schizophrenia.
  CAS PubMed Google Scholar
• Kafka, S. H. & Corbett, R. Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmacol. 295, 147–154 (1996).
  CAS PubMed Google Scholar
• Tsai, S. J. Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: a hypothesis that may explain behavioral sensitization to psychostimulants and schizophrenia. Med. Hypotheses 64, 197–200 (2005).
  CAS PubMed Google Scholar
• Lara, D. R. & Souza, D. O. Schizophrenia: a purinergic hypothesis. Med. Hypotheses 54, 157–166 (2000).
  CAS PubMed Google Scholar
• Deckert, J. et al. Up-regulation of striatal adenosine A2A receptors in schizophrenia. Neuroreport 14, 313–316 (2003).
  CAS PubMed Google Scholar
• Yee, B. K. et al. Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur. J. Neurosci. 26, 3237–3252 (2007).
  PubMed Google Scholar
• Franke, H., Kittner, H., Grosche, J. & Illes, P. Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology (Berl) 167, 187–194 (2003).
  CAS Google Scholar
• Davies, D. L. et al. Ethanol differentially affects ATP-gated P2X3 and P2X4 receptor subtypes expressed in Xenopus oocytes. Neuropharmacology 49, 243–253 (2005).
  CAS PubMed Google Scholar
• Burnstock, G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol. Sci. 22, 182–188 (2001).
  CAS PubMed Google Scholar
• Burnstock, G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol. Therap. 110, 433–454 (2006). A comprehensive review of the use of P2 receptor antagonists for the treatment of pain.
  CAS Google Scholar
• Honore, P. et al. Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain 99, 11–19 (2002).
  CAS PubMed Google Scholar
• Dorn, G. et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32, e49 (2004).
  PubMed PubMed Central Google Scholar
• Bardoni, R. et al. ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J. Neurosci. 17, 5297–5304 (1997).
  CAS PubMed PubMed Central Google Scholar
• Jo, Y. H. & Schlichter, R. Synaptic corelease of ATP and GABA in cultured spinal neurons. Nature Neurosci. 2, 241–245 (1999).
  CAS PubMed Google Scholar
• Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783 (2003). Seminal paper implicating microglial P2X 4 receptors in neuropathic pain.
  CAS PubMed Google Scholar
• McGaraughty, S. & Jarvis, M. F. Purinergic control of neuropathic pain. Drug Dev. Res. 67, 376–388 (2006).
  CAS Google Scholar
• Inoue, K. P2 receptors and chronic pain. Purinergic Signal. 3, 135–144 (2007). Updated review on P2X 3 , P2X 4 and P2X 7 receptors in neuropathic pain.
  CAS PubMed PubMed Central Google Scholar
• Scholz, J. & Woolf, C. J. The neuropathic pain triad: neurons, immune cells and glia. Nature Neurosci. 10, 1361–1368 (2007).
  CAS PubMed Google Scholar
• Coull, J. A. et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017–1021 (2005).
  CAS PubMed Google Scholar
• Nasu-Tada, K. et al. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia. Glia 53, 769–775 (2006).
  PubMed Google Scholar
• Guo, L. H., Guo, K. T., Wendel, H. P. & Schluesener, H. J. Combinations of TLR and NOD2 ligands stimulate rat microglial P2X4R expression. Biochem. Biophys. Res. Commun. 349, 1156–1162 (2006).
  CAS PubMed Google Scholar
• Tsuda, M. et al. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89–95 (2004).
  PubMed Google Scholar
• Morita, K. et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain 111, 351–359 (2004).
  CAS PubMed Google Scholar
• Inoue, K. ATP receptors of microglia involved in pain, in Novartis Foundation Symposium 276 Purinergic Signalling in Neuron–Glial Interactions 263–274 (John Wiley & Sons Ltd., Chichester, 2006).
  Google Scholar
• Trang, T., Beggs, S. & Salter, M. W. Purinoceptors in microglia and neuropathic pain. Pflugers Arch. 452, 645–652 (2006).
  CAS PubMed Google Scholar
• Chessell, I. P. et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386–396 (2005). This paper describes the loss of neuropathic pain in P2X 3 receptor knockout mice.
  CAS PubMed Google Scholar
• Chessell, I. P. et al. The role of P2X7 and P2X4 in pain processing; common or divergent pathways? Purinergic Signal. 2, 46–47 (2006).
  Google Scholar
• Guo, C., Masin, M., Qureshi, O. S. & Murrell-Lagnado, R. D. Evidence for functional P2X4/P2X7 heteromeric receptors. Mol. Pharmacol. 72, 1447–1456 (2007).
  CAS PubMed Google Scholar
• Okada, M., Nakagawa, T., Minami, M. & Satoh, M. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J. Pharmacol. Exp. Ther. 303, 66–73 (2002).
  CAS PubMed Google Scholar
• Ruan, H. Z. & Burnstock, G. Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem. Cell Biol. 120, 415–426 (2003).
  CAS PubMed Google Scholar
• Gerevich, Z. & Illes, P. P2Y receptors and pain transmission. Purinergic Signal. 1, 3–10 (2004).
  CAS PubMed PubMed Central Google Scholar
• Selden, N. R. et al. Purinergic actions on neurons that modulate nociception in the rostral ventromedial medulla. Neuroscience 146, 1808–1816 (2007).
  CAS PubMed Google Scholar
• Gerevich, Z. et al. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization. Br. J. Pharmacol. 151, 226–236 (2007).
  CAS PubMed PubMed Central Google Scholar
• Nakagawa, T. et al. Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 147, 445–455 (2007). This study shows that P2X 3 and P2X 2/3 receptor antagonists prevent the induction of tactile allodynia.
  CAS PubMed Google Scholar
• Ueno, S. et al. Involvement of P2X2 and P2X3 receptors in neuropathic pain in a mouse model of chronic constriction injury. Drug Dev. Res. 59, 104–111 (2003).
  CAS Google Scholar
• Tsuda, M., Hasegawa, S. & Inoue, K. P2X receptor-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J. Neurochem. 103, 1408–1416 (2007).
  CAS PubMed Google Scholar
• Chen, Y. et al. Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. Pain 119, 38–48 (2005).
  CAS PubMed Google Scholar
• McGaraughty, S. et al. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain. Br. J. Pharmacol. 146, 180–188 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wirkner, K., Sperlagh, B. & Illes, P. P2X3 receptor involvement in pain states. Mol. Neurobiol. 36, 165–183 (2007).
  CAS PubMed Google Scholar
• Hughes, J. P., Hatcher, J. P. & Chessell, I. P. The role of P2X7 in pain and inflammation. Purinergic Signal. 3, 163–169 (2007).
  CAS PubMed PubMed Central Google Scholar
• McGaraughty, S. et al. P2X7-related modulation of pathological nociception in rats. Neuroscience 146, 1817–1828 (2007). The authors of this study used a selective P2X 7 receptor antagonist, A438079, for the treatment of chronic pain.
  CAS PubMed Google Scholar
• McQuay, H. J. et al. A systematic review of antidepressants in neuropathic pain. Pain 68, 217–227 (1996).
  CAS PubMed Google Scholar
• Pedrazza, E. L. et al. Sertraline and clomipramine inhibit nucleotide catabolism in rat brain synaptosomes. Toxicol. In Vitro 21, 671–676 (2007).
  CAS PubMed Google Scholar
• Akkari, R., Burbiel, J. C., Hockemeyer, J. & Müller, C. E. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. Curr. Top. Med. Chem. 6, 1375–1399 (2006).
  CAS PubMed Google Scholar
• Burnstock, G. The role of adenosine triphosphate in migraine. Biomed. Pharmacother. 43, 727–736 (1989).
  CAS PubMed Google Scholar
• Ambalavanar, R., Moritani, M. & Dessem, D. Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation. Pain 117, 280–291 (2005).
  CAS PubMed Google Scholar
• Fabbretti, E. et al. Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J. Neurosci. 26, 6163–6171 (2006).
  CAS PubMed PubMed Central Google Scholar
• Chen, C. C. et al. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377, 428–431 (1995). Seminal paper reporting the cloning of P2X 3 receptors and their localization in nociceptive sensory neurons.
  CAS PubMed Google Scholar
• Fumagalli, M., Ceruti, S., Verderio, C. & Abbracchio, M. P. ATP as a neurotransmitter of pain in migraine: a functional role for P2Y receptors in primary cultures from mouse trigeminal sensory ganglia. Purinergic Signal. 2, 120–121 (2006).
  Google Scholar
• D'Arco, M. et al. Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons. J. Neurosci. 27, 8190–8201 (2007).
  CAS PubMed PubMed Central Google Scholar
• Shapiro, R. E. Caffeine and headaches. Neurol. Sci. 28, S179–S183 (2007).
  PubMed Google Scholar
• Humphrey, P. P. A. The discovery of a new drug class for the acute treatment of migraine. Headache 47, S10–S19 (2007).
  PubMed Google Scholar
• Hohoff, C. et al. An adenosine A2A receptor gene haplotype is associated with migraine with aura. Cephalalgia 27, 177–181 (2007).
  CAS PubMed Google Scholar
• Gever, J. et al. Pharmacology of P2X channels. Pflugers Arch. 452, 513–537 (2006). Good review of the identification and effectiveness of P2X receptor antagonists, including RO3, a P2X 3 antagonist that is orally bioavailable and stable in vivo.
  CAS PubMed Google Scholar
• Wilot, L. C. et al. Lithium and valproate protect hippocampal slices against ATP-induced cell death. Neurochem. Res. 32, 1539–1546 (2007).
  CAS PubMed Google Scholar
• Chang, G., Chen, L. & Mao, J. Opioid tolerance and hyperalgesia. Med. Clin. North Am. 91, 199–211 (2007).
  CAS PubMed Google Scholar
• Ho, B. T. et al. Analgesic activity of anticancer agent suramin. Anticancer Drugs 3, 91–94 (1992).
  CAS PubMed Google Scholar
• Fellin, T. et al. Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP, in Novartis Foundation Symposium 276 Purinergic Signalling in Neuron–Glial Interactions 208–221 (John Wiley & Sons Ltd., Chichester, 2006).
  Google Scholar
• Patti, L. et al. P2X7 receptors exert a permissive role on the activation of release-enhancing presynaptic α7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals. Neuropharmacology 50, 705–713 (2006).
  CAS PubMed Google Scholar
• Rodrigues, R. J. et al. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y 2, and/or P2Y4 receptors in the rat hippocampus. J. Neurosci. 25, 6286–6295 (2005).
  CAS PubMed PubMed Central Google Scholar
• Pankratov, Y., Lalo, U., Verkhratsky, A. & North, R. A. Vesicular release of ATP at central synapses. Pflugers Arch. 452, 589–597 (2006).
  CAS PubMed Google Scholar
• Bodin, P. & Burnstock, G. Purinergic signalling: ATP release. Neurochem. Res. 26, 959–969 (2001).
  CAS PubMed Google Scholar
• Montana, V. et al. Vesicular transmitter release from astrocytes. Glia 54, 700–715 (2006).
  PubMed Google Scholar
• Zhang, Z. et al. Regulated ATP release from astrocytes through lysosome exocytosis. Nature Cell Biol. 9, 945–953 (2007). An original paper describing release of ATP from astrocytes via lysosome exocytosis.
  CAS PubMed Google Scholar
• Stout, C. E., Costantin, J. L., Naus, C. C. & Charles, A. C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 277, 10482–10488 (2002).
  CAS PubMed Google Scholar
• Wall, M. J. & Dale, N. Auto-inhibition of rat parallel fibre-Purkinje cell synapses by activity-dependent adenosine release. J. Physiol. 581, 553–565 (2007).
  PubMed PubMed Central Google Scholar
• Martín, E. D. et al. Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia 55, 36–45 (2007).
  PubMed Google Scholar
• Zimmermann, H. et al. Ecto-nucleotidases, molecular properties and functional impact. An. R. Acad. Nac. Farm. 73, 537–566 (2007). An excellent update of knowledge of ecto-nucleotidases.
  CAS Google Scholar
• Burnstock, G. & Wood, J. N. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6, 526–532 (1996).
  CAS PubMed Google Scholar
• Sperlágh, B., Zsilla, G., Baranyi, M., Illes, P. & Vizi, E. S. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience 149, 99–111 (2007).
  PubMed Google Scholar
• Ribeiro, J. A., Sebastião, A. M. & de Mendonça, A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68, 377–392 (2003).
  Google Scholar
• Braganhol, E., Tamajusuku, A. S., Bernardi, A., Wink, M. R. & Battastini, A. M. Ecto-5′-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line. Biochim. Biophys. Acta 1770, 1352–1359 (2007).
  CAS PubMed Google Scholar
• Synowitz, M. et al. A1 adenosine receptors in microglia control glioblastoma-host interaction. Cancer Res. 66, 8550–8557 (2006).
  CAS PubMed Google Scholar
• Vianna, E. P., Ferreira, A. T., Doná, F., Cavalheiro, E. A. & da Silva Fernandes, M. J. Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia 46, 166–173 (2005).
  CAS PubMed Google Scholar
• Hosseinmardi, N., Mirnajafi-Zadeh, J., Fathollahi, Y. & Shahabi, P. The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats. Pharmacol. Res. 56, 110–117 (2007).
  CAS PubMed Google Scholar
• Liu, H. Q., Zhang, W. Y., Luo, X. T., Ye, Y. & Zhu, X. Z. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br. J. Pharmacol. 148, 314–325 (2006).
  CAS PubMed PubMed Central Google Scholar
• Rathbone, M. P. et al. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59, 663–690 (1999).
  CAS PubMed Google Scholar
• Reece, T. B. et al. Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma. J. Surg. Res. 121, 130–134 (2004).
  CAS PubMed Google Scholar
• Mojsilovic-Petrovic, J. et al. Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J. Neurosci. 26, 9250–9263 (2006).
  CAS PubMed PubMed Central Google Scholar
• Fuxe, K., Ferre, S., Genedani, S., Franco, R. & Agnati, L. F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 92, 210–217 (2007).
  CAS PubMed Google Scholar
• O'Neill, M. & Brown, V. J. The effect of the adenosine A2A antagonist KW-6002 on motor and motivational processes in the rat. Psychopharmacology (Berl) 184, 46–55 (2006).
  CAS Google Scholar
• Shields, C. B. et al. Treatment of spinal cord injury via topical perfusion with an ATP solution. Society for Neuroscience, Washington, DC. Abstr. 418, 8 (2004).
  Google Scholar
• Cakir, E., Baykal, S., Karahan, S. C., Kuzeyli, K. & Uydu, H. Acute phase effects of ATP-MgCl2 on experimental spinal cord injury. Neurosurg. Rev. 26, 67–70 (2003).
  PubMed Google Scholar
• Kim, D. S., Kwak, S. E., Kim, J. E., Won, M. H. & Kang, T. C. The co-treatments of vigabatrin and P2X receptor antagonists protect ischemic neuronal cell death in the gerbil hippocampus. Brain Res. 1120, 151–160 (2006).
  CAS PubMed Google Scholar
• Lin, Y., Desbois, A., Jiang, S. & Hou, S. T. P2 receptor antagonist PPADS confers neuroprotection against glutamate/NMDA toxicity. Neurosci. Lett. 377, 97–100 (2005).
  CAS PubMed Google Scholar
• Wang, Y. et al. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J. Neurosci. 23, 7958–7965 (2003).
  CAS PubMed PubMed Central Google Scholar
• Morrone, F. B. et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 6, 226 (2006).
  PubMed PubMed Central Google Scholar
• Waeber, C. & Moskowitz, M. A. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 61, S9–20 (2003).
  PubMed Google Scholar
• Dell'Antonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A. & Ferrero, M. E. Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum. 46, 3378–3385 (2002).
  CAS PubMed Google Scholar
• Witting, A., Walter, L., Wacker, J., Moller, T. & Stella, N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc. Natl Acad. Sci. USA. 101, 3214–3219 (2004).
  CAS PubMed PubMed Central Google Scholar
• Honore, P. et al. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 319, 1376–1385 (2006).
  CAS PubMed Google Scholar
• Donnelly-Roberts, D. L. & Jarvis, M. F. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol. 151, 571–579 (2007). Updated review of the use of P2X 7 receptor antagonists against chronic pain.
  CAS PubMed PubMed Central Google Scholar